Clinical Trial Update: A Multi-Dose Study With a Treatment for Open-Angle Glaucoma [Phase 2, Phase 3]

View source ↗

Summary

A multi-dose Phase 2/3 clinical trial for a treatment of open-angle glaucoma has been withdrawn, representing a status change for the study. The sponsor is Alco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma | Phase 2, Phase 3 | Status: WITHDRAWN